A transient attenuation of insulin hypersecretion in young, growing Ins1−/−:Ins2+/− mice allowed us to test the secondary hypothesis that these anti-obesity effects would persist despite late-onset HFD-induced elevations in insulin. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.